Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma.
Journal of cancer research and clinical oncology | 2014-04-01 | PMID 24509625
Zdzalik Daria, Dymek Barbara, Grygielewicz Paulina and 5 more
Genes: ALK
